Evaluation of novel histone deacetylase inhibitors as therapeutic agents for colorectal adenocarcinomas compared to established regimens with the histoculture drug response assay (Q46335556)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Evaluation of novel histone deacetylase inhibitors as therapeutic agents for colorectal adenocarcinomas compared to established regimens with the histoculture drug response assay	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18830613

Evaluation of novel histone deacetylase inhibitors as therapeutic agents for colorectal adenocarcinomas compared to established regimens with the histoculture drug response assay (English)

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18830613

1 reference

based on heuristic

inferred from title

author name string

Jin C Kim

1

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18830613

Dae D Kim

2

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18830613

Yoo M Lee

3

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18830613

Tae W Kim

4

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18830613

Dong H Cho

5

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18830613

Moon B Kim

6

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18830613

Seong G Ro

7

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18830613

Seon Y Kim

8

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18830613

Yong S Kim

9

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18830613

Jung S Lee

10

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18830613

publication date

1 October 2008

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18830613

International Journal of Colorectal Disease

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18830613

24

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18830613

2

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18830613

209-218

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18830613

Direct role of PDGF-BB in lymphangiogenesis and lymphatic metastasis

1 reference

https://api.crossref.org/works/10.1007%2FS00384-008-0590-1

21 January 2018

Anti-cancer effects of butyrate: use of micro-array technology to investigate mechanisms

1 reference

https://api.crossref.org/works/10.1007%2FS00384-008-0590-1

21 January 2018

Induction of HDAC2 expression upon loss of APC in colorectal tumorigenesis

1 reference

https://pubmed.ncbi.nlm.nih.gov/18830613

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Heterogeneity of chemosensitivity of colorectal adenocarcinoma determined by a modified ex vivo ATP-tumor chemosensitivity assay (ATP-TCA).

1 reference

https://pubmed.ncbi.nlm.nih.gov/18830613

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Histone deacetylase inhibitors specifically kill nonproliferating tumour cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/18830613

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dimethyl sulfoxide to vorinostat: development of this histone deacetylase inhibitor as an anticancer drug

1 reference

https://pubmed.ncbi.nlm.nih.gov/18830613

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

UFT and its metabolites inhibit the angiogenesis induced by murine renal cell carcinoma, as determined by a dorsal air sac assay in mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/18830613

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The histone-deacetylase inhibitor SAHA potentiates proapoptotic effects of 5-fluorouracil and irinotecan in hepatoma cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/18830613

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vitro detection of cross-resistant and non-cross-resistant agents with fluorouracil for patients with colorectal cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/18830613

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical applications of the histoculture drug response assay.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18830613

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The histone deacetylase inhibitor PXD101 synergises with 5-fluorouracil to inhibit colon cancer cell growth in vitro and in vivo.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18830613

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chemosensitivity testing of human tumors using a microplate adenosine triphosphate luminescence assay: clinical correlation for cisplatin resistance of ovarian carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/18830613

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Molecular markers of chemotherapeutic response and toxicity in colorectal cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/18830613

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Development of histone deacetylase inhibitors for cancer treatment

1 reference

https://pubmed.ncbi.nlm.nih.gov/18830613

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prediction of survival in patients with head and neck cancer using the histoculture drug response assay

1 reference

https://pubmed.ncbi.nlm.nih.gov/18830613

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Potential of the histoculture drug-response assay to contribute to cancer patient survival

1 reference

https://pubmed.ncbi.nlm.nih.gov/18830613

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Distribution of carcinoembryonic antigen and biologic behavior in colorectal carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/18830613

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Epigenetic approaches to cancer therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/18830613

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chemotherapy in metastatic colorectal cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/18830613

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Histoculture drug response assay to monitor chemoresponse

1 reference

https://pubmed.ncbi.nlm.nih.gov/18830613

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

TCA-100 tumour chemosensitivity assay: differences in sensitivity between cultured tumour cell lines and clinical studies.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18830613

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Correlation between thymidylate synthase and dihydropyrimidine dehydrogenase mRNA level and in vitro chemosensitivity to 5-fluorouracil, in relation to differentiation in gastric cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/18830613

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Response to chemotherapy (irinotecan plus 5-fluorouracil) in colorectal carcinoma can be predicted by tumour DNA content

1 reference

https://pubmed.ncbi.nlm.nih.gov/18830613

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rapid in vitro chemosensitivity analysis of human colon tumor cell lines

1 reference

https://pubmed.ncbi.nlm.nih.gov/18830613

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Aneuploidy-cancer predisposition syndromes: a new link between the mitotic spindle checkpoint and cancer.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18830613

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chemotherapy for colorectal cancer in the metastatic and adjuvant setting: past, present and future

1 reference

https://pubmed.ncbi.nlm.nih.gov/18830613

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The histone deacetylase inhibitor butyrate downregulates cyclin B1 gene expression via a p21/WAF-1-dependent mechanism in human colon cancer cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/18830613

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/18830613

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Appraisal of the MTT-based assay as a useful tool for predicting drug chemosensitivity in leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/18830613

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

HDAC inhibitors: clinical update and mechanism-based potential.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18830613

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adenosine triphosphate-based chemotherapy response assay (ATP-CRA)-guided platinum-based 2-drug chemotherapy for unresectable nonsmall-cell lung cancer.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18830613

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reintroduction of Oxaliplatin Is Associated With Improved Survival in Advanced Colorectal Cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/18830613

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chemosensitivity testing of ovarian cancer using the histoculture drug response assay: sensitivity to cisplatin and clinical response

1 reference

https://pubmed.ncbi.nlm.nih.gov/18830613

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The histone deacetylase inhibitor suberoylanilide hydroxamic acid induces apoptosis via induction of 15-lipoxygenase-1 in colorectal cancer cells.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18830613

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vivo-like drug responses of human tumors growing in three-dimensional gel-supported primary culture

1 reference

https://pubmed.ncbi.nlm.nih.gov/18830613

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00384-008-0590-1

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18830613

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18830613

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46335556&oldid=2207805897"